The Cost-effectiveness of Treating Diabetic Lower Extremity Ulcers with Becaplermin (Regranex): A Core Model with an Application Using Swedish Cost Data.
Research output: Contribution to journal › Article
|Research areas and keywords||
Subject classification (UKÄ) – MANDATORY
|Journal||Value in Health|
|Volume||3 Suppl 1|
|Publication status||Published - 2000|
The information about affiliations in this record was updated in December 2015. The record was previously connected to the following departments: Pediatrics/Urology/Gynecology/Endocrinology (013240400), Section I-II (013230011), Diabetes and Endocrinology (013241530)